Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550271
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-09
Brief Title:
The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals A Retrospective Study and Review With Clinical Implications
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study collected real-world evidence to better understand and define the relative bioavailability ratio between compounded rapamycin and generic rapamycin with a specific focus on relative efficacy in increasing rapamycin levels in the blood blood rapamycin levels
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None